PNC Financial Services Group’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
22,333
-2,959
-12% -$203K ﹤0.01% 1141
2026
Q1
$1.62M Buy
25,292
+92
+0.4% +$6.38K ﹤0.01% 1083
2025
Q4
$2M Buy
25,200
+54
+0.2% +$4.56K ﹤0.01% 975
2025
Q3
$1.66M Buy
25,146
+6
+0% +$357 ﹤0.01% 1031
2025
Q2
$1.33M Buy
25,140
+1,440
+6% +$67.6K ﹤0.01% 1074
2025
Q1
$1.18M Hold
23,700
﹤0.01% 1099
2024
Q4
$1.5M Hold
23,700
﹤0.01% 1013
2024
Q3
$1.16M Hold
23,700
﹤0.01% 1116
2024
Q2
$1.07M Sell
23,700
-2
-0% -$68 ﹤0.01% 1111
2024
Q1
$1.48M Buy
23,702
+13,702
+137% +$888K ﹤0.01% 1009
2023
Q4
$578K Buy
10,000
+5,990
+149% +$307K ﹤0.01% 1435
2023
Q3
$188K Hold
4,010
﹤0.01% 2159
2023
Q2
$178K Buy
+4,010
New +$142K ﹤0.01% 2288

Other funds holding IRON

PNC Financial Services Group's IRON Position: Q2 2026 in Review

PNC Financial Services Group reduced its Disc Medicine (IRON) stake by 12% in Q2 2026, selling an estimated $203K and leaving 22,333 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

PNC Financial Services Group first reported a position in IRON in Q2 2023 and has held it in 13 quarters since. The position peaked at $2M in Q4 2025. 72 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • PNC Financial Services Group held 22,333 shares of Disc Medicine worth $1.63M as of Q2 2026.
  • PNC Financial Services Group sold 2,959 Disc Medicine shares in Q2 2026, an estimated $203K.
  • Disc Medicine made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1141 holding.
  • PNC Financial Services Group first reported a position in Disc Medicine in Q2 2023 and has held it in 13 quarters since.
  • PNC Financial Services Group's Disc Medicine position peaked at $2M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.